Moreover, both PRMT5‐WT and the enzyme activity‐deficient mutant had no effect on the methylation of the KLF5‐R41K mutation, indicating that PRMT5 mainly methylates KLF5 at arginine 41 in lung cancer cells. The gene discussed is KLF5; the disease is lung cancer.